NEW YORK (GenomeWeb News) — In a move that may transform the flow cytometry industry, start-up biotech Accuri Cytometers last week launched a flow cytometer that it believes is as good as or better than market-leading instruments with similar specifications, but costs about 75 percent less.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.